
    
      Participants will be randomized into two groups. Concentrated Bone Marrow Aspirate (BMAC) or
      Platelet-Rich Plasma (PRP). BMAC subjects will have bone marrow aspirated from the subjects
      iliac crests and the cellular rich portion will be concentrated and subsequently injected
      into the subjects' symptomatic knee. BMAC patients will also have a venous whole blood drawn
      from the antecubital vein to simulate a PRP procedure. PRP subjects will have the same venous
      blood draw from the antecubital vein with subsequent platelet concentration. The resulting
      PRP will be injected into the symptomatic knee. PRP subjects will also undergo a bone marrow
      aspiration from the iliac crest to simulate the BMAC procedure. Follow-up at 1 week, 6 weeks,
      6 months, and 12 months after injection, with repeat radiographs at 12 months.
    
  